XML 35 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
OPERATING AND REPORTABLE SEGMENTS (Tables)
 9 Months Ended
Sep. 30, 2013
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
Segment Reporting Information
(in thousands)
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2013
 
2012
 
2013
 
2012
Results of Operations:
 
 
 
 
 
 
 
Revenue:
 
 
 
 
 
 
 
Infusion Services - product revenue
$
169,011

 
$
123,361

 
$
469,594

 
$
338,721

Infusion Services - service revenue
5,791

 
2,575

 
15,750

 
7,242

Total Infusion Services revenue
174,802

 
125,936

 
485,344

 
345,963

 
 
 
 
 
 
 
 
Home Health Services - service revenue
18,071

 
17,299

 
54,240

 
50,870

 
 
 
 
 
 
 
 
PBM Services - service revenue
16,006

 
27,130

 
59,099

 
85,066

 
 
 
 
 
 
 
 
Total revenue
$
208,879

 
$
170,365

 
$
598,683

 
$
481,899

 
 
 
 
 
 
 
 
Adjusted EBITDA by Segment before corporate overhead:
 
 
 

 
 
 
 

Infusion Services
$
14,693

 
$
9,931

 
$
41,201

 
$
25,740

Home Health Services
567

 
1,402

 
2,547

 
3,557

PBM Services
4,278

 
6,905

 
15,397

 
19,367

Total Segment Adjusted EBITDA
19,538

 
18,238

 
59,145

 
48,664

 
 
 
 
 
 
 
 
Corporate overhead
(7,483
)
 
(6,625
)
 
(23,531
)
 
(19,665
)
 
 
 
 
 
 
 
 
Interest expense, net
(7,182
)
 
(6,497
)
 
(20,168
)
 
(19,705
)
Loss on extinguishment of debt
(15,898
)
 
—

 
(15,898
)
 
—

Income tax benefit
587

 
2,506

 
31

 
2,644

Depreciation
(3,269
)
 
(2,134
)
 
(8,298
)
 
(6,115
)
Amortization of intangibles
(1,009
)
 
(1,087
)
 
(4,801
)
 
(2,844
)
Stock-based compensation expense
(1,427
)
 
(1,687
)
 
(7,260
)
 
(4,398
)
Acquisition and integration expenses
(4,890
)
 
(998
)
 
(13,025
)
 
(1,806
)
Restructuring and other expenses and investments
(1,409
)
 
(2,321
)
 
(4,424
)
 
(3,696
)
Loss from continuing operations, net of income taxes
$
(22,442
)
 
$
(605
)
 
$
(38,229
)
 
$
(6,921
)
 
 
 
 
 
 
 
 
Supplemental Operating Data
 

 
 

 
 
 
 
 
 
 
 
 
September 30,
2013
 
December 31,
2012
Total Assets:
 

 
 

 
 
 
 
Infusion Services
 
 
 
 
$
776,878

 
$
438,623

Home Health Services
 
 
 
 
63,402

 
62,403

PBM Services
 
 
 
 
32,363

 
36,354

Corporate unallocated, including cash and cash equivalents
 
 
 
 
53,641

 
95,813

Assets associated with discontinued operations, not sold
 
 
 
 
16

 
9,183

Total
 
 
 
 
$
926,300

 
$
642,376